FDA’s Ganley Floats Limited-Launch Switch Concept
This article was originally published in The Tan Sheet
OTC office Director Charles Ganley suggests a novel switch sponsor might make its product available within a limited geographical area, for instance, “to make sure we get it right.”
You may also be interested in...
Consumer health product firms say the coronavirus will have an impact on their results, but it’s too early to estimate the costs. US FDA also hedges its predictions, saying the outbreak could lead to interruptions in country’s drug and medical device supplies. China's health commission has issued six guidelines for diagnosis and treatment, but no conventional antiviral treatment is approved and it's emphasizing traditional Chinese medicines.